BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30740609)

  • 1. Condoliase for treatment of lumbar disc herniation.
    Matsuyama Y; Chiba K
    Drugs Today (Barc); 2019 Jan; 55(1):17-23. PubMed ID: 30740609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Condoliase for the Treatment of Lumbar Disc Herniation: A Randomized Controlled Trial.
    Chiba K; Matsuyama Y; Seo T; Toyama Y
    Spine (Phila Pa 1976); 2018 Aug; 43(15):E869-E876. PubMed ID: 29257028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, double-blind, dose-finding study of condoliase in patients with lumbar disc herniation.
    Matsuyama Y; Chiba K; Iwata H; Seo T; Toyama Y
    J Neurosurg Spine; 2018 May; 28(5):499-511. PubMed ID: 29424676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter Retrospective Analysis of Intradiscal Condoliase Injection Therapy for Lumbar Disc Herniation.
    Oshita Y; Matsuyama D; Sakai D; Schol J; Shirasawa E; Emori H; Segami K; Takahashi S; Yagura K; Miyagi M; Saito W; Imura T; Nakazawa T; Inoue G; Hiyama A; Katoh H; Akazawa T; Kanzaki K; Sato M; Takaso M; Watanabe M
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation.
    Takeuchi S; Hanakita J; Takahashi T; Inoue T; Minami M; Suda I; Nakamura S; Kanematsu R
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of chemonucleolysis with condoliase for treatment of painful lumbar disc herniation.
    Okada E; Suzuki S; Nori S; Tsuji O; Nagoshi N; Yagi M; Fujita N; Nakamura M; Matsumoto M; Watanabe K
    J Orthop Sci; 2021 Jul; 26(4):548-554. PubMed ID: 32713796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Condoliase therapy for lumbar disc herniation -2 year clinical outcome.
    Banno T; Hasegawa T; Yamato Y; Yoshida G; Arima H; Oe S; Ide K; Yamada T; Kurosu K; Nakai K; Matsuyama Y
    J Orthop Sci; 2024 Jan; 29(1):64-70. PubMed ID: 36424250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term clinical and radiographic outcomes of chemonucleolysis with condoliase for painful lumbar disc herniation and analysis regarding intradiscal injection area.
    Ohtonari T; Torii R; Noguchi S; Kitagawa T; Nishihara N
    Neurosurg Rev; 2023 Feb; 46(1):59. PubMed ID: 36813932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Chemonucleolysis With Condoliase in Cynomolgus Monkeys.
    Muramatsu D; Yamaguchi H; Minamisawa Y; Nii A
    Toxicol Pathol; 2020 Jul; 48(5):656-668. PubMed ID: 32633701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemonucleolysis with Chondroitin Sulfate ABC Endolyase for Treating Lumbar Disc Herniation: Exploration of Prognostic Factors for Good or Poor Clinical Outcomes.
    Ishibashi K; Fujita M; Takano Y; Iwai H; Inanami H; Koga H
    Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33228119
    [No Abstract]   [Full Text] [Related]  

  • 11. Intradiscal Injection with Condoliase (Chondroitin Sulfate ABC Endolyase) for Painful Radiculopathy Caused by Lumbar Disc Herniation.
    Hirai T; Takahashi T; Tanaka T; Motoyoshi T; Matsukura Y; Yuasa M; Inose H; Yoshii T; Okawa A
    Spine Surg Relat Res; 2022; 6(3):252-260. PubMed ID: 35800623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic chemonucleolysis for lumbar disc herniation-an assessment of historical and contemporary efficacy and safety: a systematic review and meta-analysis.
    Schol J; Ambrosio L; Tamagawa S; Joyce K; Ruiz-Fernández C; Nomura A; Sakai D
    Sci Rep; 2024 Jun; 14(1):12846. PubMed ID: 38834631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Term Outcome and Predictors of Therapeutic Effects of Intradiscal Condoliase Injection for Patients with Lumbar Disc Herniation.
    Nakajima H; Kubota A; Maezawa Y; Watanabe S; Honjoh K; Ohmori H; Matsumine A
    Spine Surg Relat Res; 2021; 5(4):264-271. PubMed ID: 34435150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of condoliase for lumbar disc herniation: a systematic review and meta-analysis.
    Huang Z; Xu B; Liu Y; Chen H; Cai X; Zhang L; Shen X; Li Y
    Front Pharmacol; 2023; 14():1151998. PubMed ID: 37670940
    [No Abstract]   [Full Text] [Related]  

  • 15. Disc degeneration could be recovered after chemonucleolysis with condoliase.-1 year clinical outcome of condoliase therapy.
    Banno T; Hasegawa T; Yamato Y; Yoshida G; Arima H; Oe S; Mihara Y; Yamada T; Ide K; Watanabe Y; Kurosu K; Nakai K; Matsuyama Y
    J Orthop Sci; 2022 Jul; 27(4):767-773. PubMed ID: 34144880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on chemonucleolysis.
    Brown MD
    Spine (Phila Pa 1976); 1996 Dec; 21(24 Suppl):62S-68S. PubMed ID: 9112326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental chemonucleolysis with chondroitinase ABC.
    Kato F; Iwata H; Mimatsu K; Miura T
    Clin Orthop Relat Res; 1990 Apr; (253):301-8. PubMed ID: 2317986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with disc degeneration based on Pfirrmann criteria after condoliase treatment for lumbar disc herniation.
    Kobayashi K; Sato K; Ando T
    J Orthop Sci; 2023 Sep; 28(5):976-983. PubMed ID: 36030156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regenerative effects of platelet-rich plasma releasate injection in rabbit discs degenerated by intradiscal injection of condoliase.
    Hasegawa T; Akeda K; Yamada J; Kawaguchi K; Takegami N; Fujiwara T; Natsume T; Ide K; Matsuyama Y; Sudo A
    Arthritis Res Ther; 2023 Nov; 25(1):216. PubMed ID: 37941067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemonucleolysis for sciatica. A critical review.
    Nachemson AL; Rydevik B
    Acta Orthop Scand; 1988 Feb; 59(1):56-62. PubMed ID: 3281406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.